The pond-raised channel catfish (Ictalurus punctatus) industry in the United States of America can incur losses of over a $100 million annually due to bacterial diseases including columnaris disease caused by Flavobacterium columnare. One management approach available to catfish producers is the use of medicatedfeed containing antibiotics. However, the negative attributes of antibiotic use in agriculture include public concerns and the potential development of antibiotic-resistant bacteria. Therefore, the discovery of environmentally-safe natural compounds for use as therapeutic agents would greatly benefit the catfish industry. In this study, a rapid bioassay was used to evaluate crude plant extracts as the first step in the discovery of natural therapeutants. Plant extracts from Terminalia brownii were found to be inhibitory towards F. columnare. The minimum inhibitory concentration (MIC) of the 5% water-methanol extract of T. brownii (stem bark) was 10 μg/mL and the 24 h 50% inhibition concentration (IC 50 ) was 40 μg/mL. Subsequent bioassay-guided fractionation of the T. brownii ethanol extract using reverse phase C-4 chromatography revealed the highest level of activity in the aqueous:methanol (50:50) fraction. HPLC analysis and subsequent purification of this fraction provided two compounds identified as ellagic acid (1) and 4-O-(3′′,4′′-di-O-galloyl--L-rhamnopyranosyl)ellagic acid (2). Compound 2 was the most active isolated compound, with a minimum inhibitory concentration (MIC) of 10±0 µg/mL and 24 h IC 50 of 31±1 µg/mL. Although 1 was more active according to a MIC of 6±5 µg/mL, its 24 h IC 50 was >100 µg/mL, and, therefore, it was less active overall of the two most active isolated compounds.
One of the largest segments of United States of America (USA) aquaculture is the pond-raised channel catfish [Ictalurus punctatus Rafinesque (Ictaluridae)] industry. The two most common bacterial diseases encountered in cultured catfish are enteric septicemia of catfish (ESC) and columnaris, which are caused by the bacteria Edwardsiella ictaluri Hawke (Enterobacteriaceae) and Flavobacterium columnare Davis (Flavobacteriaceae), respectively. These two diseases combined can cause economic losses of over $100 million annually to the USA catfish industry [1] . One management approach to help reduce catfish mortality from ESC and columnaris is the use of medicated (antibiotic-laden) feed (e.g., Aquaflor ® ), though some catfish producers are using this method less frequently. The future use of antibiotics in medicated feed in catfish aquaculture is uncertain due to public concerns about the environmental impact and potential development of antibiotic resistant strains of E. ictaluri and F. columnare. Other management approaches include fish vaccines [2, 3] and chemotherapeutic agents such as potassium permanganate (KMnO 4 ) and copper sulfate pentahydrate (CuSO 4 ·H 2 O) for columnaris treatment [4] . These chemotherapeutants have several drawbacks, including high phytotoxicity, adverse interaction with water quality, and broadspectrum toxicity that require careful application to avoid catfish mortality.
The discovery of natural therapeutic agents that are environmentally benign, have a low impact on water quality, and are highly selective against E. ictaluri and F. columnare would greatly benefit the pondraised channel catfish industry. As the first stage of the discovery process, we have been evaluating marine and plant extracts to discover promising compounds for use as novel therapeutants. In this study, we used bioassay-guided fractionation to isolate several compounds from bark extracts of Terminalia brownii Fresen. (Combretaceae) that possess antibacterial activity towards F. columnare. (Tables 1 and 2 ). Due to the lower toxicity of the crude extract and the first set of crude extract fractions (liquid/liquid) towards E. ictaluri compared with F. columnare, the activities of subsequent fractions and isolated compounds towards this bacterial pathogen were not evaluated. 
Bioassay evaluation of the C4 column fractions revealed that fraction 150C (H 2 O/methanol 75:25 partition) was the most toxic towards F. columnare based upon a mean MIC of 6 µg/mL and MIC RDCF and RDCO values of 1 and 10 µg/mL, respectively (Table 3) . Fraction 150C underwent preparative liquid chromatography purification to reveal five separated compounds (155A, 155B, 155C, 155D and 155E, in order of increasing retention times). Of these, compound 155D was determined to be the most toxic towards F. columnare based upon MIC and 24 h IC 50 results (Table 3) . Compound 155A, the first isolated compound to be identified, was determined to be ellagic acid (1) . Based upon MIC results and MIC RDCF and RDCO values, ellagic acid was found to possess similar toxicity towards F. columnare when compared with compound 155A (Table 3) . Isolated compound 155D was identified as (Figure 1) . Compound 2 had a MIC of 10±0 µg/mL and a 24 h IC 50 of 31±1 µg/mL, while 1 had a MIC of 6±5 µg/mL and a 24 h IC 50 >100 µg/mL. Ellagic acid had a MIC of 10±0 µg/mL, very similar to that of 1, and the 24 h IC 50 of >100 µg/mL was the same as for 1.
Plants from the genus Terminalia have long been known for their medicinal uses in traditional medicine in several countries of Africa including Kenya, Tanzania, and Ethiopia. Different parts of these plants are used to treat a variety of ailments. For example, barks from the stems are boiled and then ingested or chewed directly to provide relief from gonorrhea, hepatitis, malaria, urogenital infections, and yellow fever [5] . The antibacterial activities of various extracts from Terminalia spp. towards certain human pathogenic bacteria have been confirmed recently [6] . In addition, water extracts of the leaves from the Indian almond, T. catappa, were found to inhibit the growth of two strains of Aeromonas hydrophila, a pathogenic bacterium of Nile tilapia (Oreochromis niloticus) [7] . The leafy deciduous tree T. brownii is endemic to central Africa, and parts of the plant are used in Tanzania to treat gastrointestinal conditions (e.g., diarrhea) [8] . Previous research [5] evaluated the antimicrobial activity of extracts of stem bark, stem wood and whole roots of T. brownii towards 8 species of bacteria. In that study, the extracts from the whole roots were more active against the bacteria tested than the extracts from the stem bark and stem wood. In addition, it was determined that the methanolic extract of the stem bark was the most active against S. aureus and the Gram-positive Bacillus anthracis compared with the other extracts tested including light petroleum, dichloromethane, dichloromethane:methanol, and water extracts.
In our study, the antibacterial activity of the 5% water-methanol crude extract of T. brownii against F. columnare was attributed to the two isolated compounds 1 and 2 present in the extract. A previous study [9] investigating antimicrobial activities of stem bark extracts of T. brownii also isolated and identified 2 as possessing antibacterial activity against the Gram-negative bacterium Pseudomonas aeruginosa, with an IC 50 of 8.8 µg/mL and thereby indicating greater susceptibility to 2 than F. columnare, with a 24 h IC 50 = 31±1 µg/mL (Table 3) . Before conducting efficacy/challenge studies, further evaluation of the potential toxicity of the active compounds towards non-target organisms (e.g., channel catfish) will need to be determined. The lack of antibacterial activity of 1 against F. columnare when based on IC 50 results may be due to the ability of F. columnare to overcome the initial toxicity and growth inhibition of 1 within a 24 h period, as indicated by the low MIC values (Table 3) . Therefore, in our bioassay [1] , we chose to include both MIC and 24 h IC 50 bioassay results when testing natural compounds to evaluate better their potential as antibacterial agents. The greater activity of fraction 150C based on a 24 h IC 50 of 9±0 µg/L when compared to 1 (24 h IC 50 >100 µg/L) ( Table 3 ) may be due in part to the lack of water solubility of 1 compared with ellagitannins, which are more water soluble and may act to increase their bioavailability. However, the potential of 1 to help prevent disease in fish is still promising because 1 has been found to be an immunostimulant and to enhance the antioxidant activity of tissues of rainbow trout (Oncorhynchus mykiss) when included in experimental diets [10] . This current study is the first to report the Antibacterials form Terminalia brownii Natural Product Communications Vol. 11 (11) Bioassay conditions: Crude extract, extract fractions, isolated compounds, and ellagic acid (purity 95%) (Sigma-Aldrich, St. Louis, Missouri) were evaluated for antibacterial activity by using a rapid 96-well microplate bioassay and previously published procedures [1] . Florfenicol and oxytetracycline, antibiotics used in medicated feed, were included as positive drug controls for each assay. In addition, control wells (no test compound added) were included in each assay.
The crude extract, extract fractions, isolated compounds 150A-150D, and ellagic acid were dissolved in methanol (100%) while isolated compound 150E was dissolved in dichloromethane (100%), the partition solvent used to obtain it from fraction 147C. All of the solvents used were technical grade quality (Fisher Scientific Co., Norcross, Georgia). Final concentrations of crude extract, fractions, and test compounds in the microplate wells were 0.01, 0.1, 1, 10, and 100 µg/mL. Three replications were used for controls and each dilution of the crude extract, fractions, and test compounds.
Sterile 96-well polystyrene microplates (Costar; Corning, Inc., Acton, Massachusetts) with flat-bottom wells were used to conduct the bioassay for the crude extract, fractions, and test compounds that were dissolved in methanol. In order to prevent solvent interaction with the polystyrene, sterile 96-well quartz microplates (Hellma Cells, Inc., Forest Hills, New York) were used for test compound 150E dissolved in dichloromethane. Dissolved test extract, fractions, and compounds were added to microplate wells (10 μL/well). Solvents were allowed to evaporate completely before standardized bacterial culture (0.5 MacFarland) was added to the microplate wells (200 μL/well). Microplates were incubated at 29 o C. A Packard model SpectraCount microplate photometer (Packard Instrument Company, Meriden, Connecticut) was used to measure the absorbance of the wells at 630 nm at time 0 and 24 h and at 570 nm for the cell viability portion of the assay (an additional 24 h of incubation) in which 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) was added aseptically to the wells. The MTT had previously been dissolved in phosphatebuffered saline (pH 7.2) (5 mg/mL) and filter sterilized (0.22 μm filter). Bioassays were repeated for the crude extract, active fractions, isolated compounds, and ellagic acid. However, additional inclusion of E. ictaluri in the bioassay was limited to ellagic acid since the crude extract and none of the fractions from the initial fractionation appeared very active.
The means and standard deviations of absorbance measurements were calculated, graphed, and compared with controls to determine the 24 h 50% Inhibition Concentration (IC 50 ) and 24 h Minimum Inhibitory Concentration (MIC) for each test compound. The 24 h IC 50 and MIC results for each compound tested were divided by the respective 24 h IC 50 and MIC results obtained for the positive controls florfenicol and oxytetracycline to determine the relative-todrug-control florfenicol (RDCF) and relative-to-drug-control oxytetracycline (RDCO) values. The RDCF and RDCO values provide an indication of the effectiveness of the test material (extract, compound, etc.) to the antibiotics used to manage these bacterial diseases in catfish aquaculture.
Chemical instrumentation: 1 H-and 13 C-NMR spectra were recorded in CDCl 3 on a Varian ANOVA 400 MHz spectrometer (Palo Alto, CA). All 13 C multiplicities were deduced from 90º and 135º DEPT experiments. High-resolution mass spectra were obtained using an Agilent 1100 HPLC coupled to a JEOL AccuTOF (JMS-T100LC) (Peabody, MA). Column chromatography was performed using a Biotage, Inc. Horizon TM Pump (Charlottesville, Virginia) equipped with a Horizon TM Flash Collector and fixed wavelength (254 nm) detector. HPLC method development work was performed using an Agilent 1100 system equipped with a quaternary pump, autosampler, diode-array detector, and vacuum degasser. Semi-preparative HPLC purifications were performed using a Waters Delta-Prep system (Milford, MA) equipped with a diode-array detector and a binary pump.
High-resolution LC-MS analysis:
All isolated compounds/fractions were prepared in MeOH and injected directly into a 0.3 mL/min stream of either 100% MeOH or 80% MeOH:20% deionized (DI) H 2 O. Twenty L of sample (approximately 0.1 mg/mL) was injected manually at 0.5 min while mass drift compensation standards [L-tryptophan (negative ion), PEG (positive ion)] were injected at 1.5 min over the course of a 2 min run.
Plant material:
The plant material was collected from Machakos County, Kenya, and a voucher specimen (JOM2005/002) was deposited at the University Herbarium, School of Biological Sciences, University of Nairobi, in August, 2005.
Crude extract: Approximately 10 g of 5% water-methanol extract (NP#52947) from the dried stem bark of Terminalia brownii was obtained from the collection repository of the National Center for Natural Products Research, Thad Cochran Research Center, University of Mississippi. The stem bark material was originally collected from T. brownii located in Kenya.
Purification:
The crude 5% water-methanol extract of T. brownii (9.9 g) was dissolved in 400 mL of a 90% MeOH:10% DI H 2 O solution and placed in a 2 L separation funnel. This solution was extracted thrice with 400 mL of n-hexane providing 127 mg of nhexane extractables (147A) after drying by rotary evaporation. Deionized H 2 O (114 mL) was added to the funnel effectively changing the methanol and water solvent ratio to a 70%:30% solution. This solution was extracted thrice using 400 mL aliquots of chloroform providing 1.38 g of chloroform extractables (147B), 5.93 g of methanol:DI H 2 O (70:30) extractables (147C), and 390 mg of an emulsion between these two layers (147D). [11] .
